David Oslin of the Perelman School of Medicine comments on weaning elderly patients off medications they were prescribed to years ago.
Health & Medicine
Rose Nolen-Walston of the School of Veterinary Medicine comments on the effectiveness of the nasal strips used to help prevent bleeding in horses’ lungs.
Bridgette Brawner of the Perelman School of Medicine explains “geobehavioral vulnerability” and discusses HIV risk.
Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.
Yvette Sheline of the Perelman School of Medicine is quoted about leading a study on how antidepressants may be useful in boosting moods and preventing dementia.
Penn Researcher Studies Effects of Common Anti-depressant on Brain Peptide Thought to be Responsible for the Development of Alzheimer's
A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer’s disease (AD).
Penn Study Reveals Breastfeeding, Birth Control Pills May Reduce Ovarian Cancer Risk Among Women with BRCA Gene Mutations
Breastfeeding, tubal ligation – also known as having one’s “tubes tied” – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA gene mutations, according to a comprehensive analysis from a team at the University of Pennsylvania's Basser Research Center for BRCA and the
Study from Penn Medicine's Abramson Cancer Center Helps Dispel Commonly-Held Beliefs about Cancer Care and Patient Demands for Treatment
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results from a study that will be presented by researchers in the Abramson Cancer Center (ACC) and the Perelma
While large genetic testing panels promise to uncover clues about patients’ DNA, a team of researchers from Penn Medicine’s Abramson Cancer Center (ACC) has found that those powerful tests tend to produce more questions than they answer.